Recruiting Pediatric Cancer Studies in Denver
Neuroblastoma Maintenance Therapy Trial
Difluoromethylornithine (DFMO) will be used in an open label, single agent, multicenter, study for patients with neuroblastoma in remission. In this study subjects will receive 730 Days of oral difluo...
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
The main purpose of the master is to help the research sites and sponsor carry out several clinical trials more efficiently by providing a common research protocol. Individual clinical trials under th...
About Pediatric Cancer Clinical Trials in Denver
Pediatric cancers include a wide range of cancers occurring in children and adolescents, with leukemia, brain tumors, and lymphoma being most common. Overall cure rates have improved dramatically to about 80%. Treatment includes chemotherapy, surgery, radiation, and newer immunotherapies.
There are currently 2 pediatric cancer clinical trials recruiting participants in Denver, CO. These studies are seeking a combined 546 participants. Research is being sponsored by Giselle Sholler, Eli Lilly and Company. Clinical trial participation is free and participants receive study-related medical care at no cost.
Pediatric Cancer Clinical Trials in Denver — FAQ
Are there pediatric cancer clinical trials in Denver?
Yes, there are 2 pediatric cancer clinical trials currently recruiting in Denver, CO. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Denver?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Denver research site will contact you about next steps.
Are clinical trials in Denver free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Denver studies also compensate for your time and travel.
What pediatric cancer treatments are being tested?
The 2 active trials in Denver are testing new therapies including novel drugs, biologics, and treatment approaches for pediatric cancer.
Data updated March 2, 2026 from ClinicalTrials.gov